Your browser doesn't support javascript.
loading
New P2X3 receptor antagonists. Part 1: Discovery and optimization of tricyclic compounds.
Szántó, Gábor; Makó, Attila; Bata, Imre; Farkas, Bence; Kolok, Sándor; Vastag, Mónika; Cselenyák, Attila.
Affiliation
  • Szántó G; Gedeon Richter Plc, Budapest 10, PO Box 27, H-1475, Hungary.
  • Makó A; Gedeon Richter Plc, Budapest 10, PO Box 27, H-1475, Hungary.
  • Bata I; Gedeon Richter Plc, Budapest 10, PO Box 27, H-1475, Hungary.
  • Farkas B; Gedeon Richter Plc, Budapest 10, PO Box 27, H-1475, Hungary.
  • Kolok S; Gedeon Richter Plc, Budapest 10, PO Box 27, H-1475, Hungary.
  • Vastag M; Gedeon Richter Plc, Budapest 10, PO Box 27, H-1475, Hungary.
  • Cselenyák A; Gedeon Richter Plc, Budapest 10, PO Box 27, H-1475, Hungary.
Bioorg Med Chem Lett ; 26(16): 3896-904, 2016 08 15.
Article in En | MEDLINE | ID: mdl-27423478

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Mesylates / Receptors, Purinergic P2X3 / Purinergic P2X Receptor Antagonists / Heterocyclic Compounds / Heterocyclic Compounds, 3-Ring Limits: Humans Language: En Journal: Bioorg Med Chem Lett Journal subject: BIOQUIMICA / QUIMICA Year: 2016 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Mesylates / Receptors, Purinergic P2X3 / Purinergic P2X Receptor Antagonists / Heterocyclic Compounds / Heterocyclic Compounds, 3-Ring Limits: Humans Language: En Journal: Bioorg Med Chem Lett Journal subject: BIOQUIMICA / QUIMICA Year: 2016 Document type: Article Affiliation country: Country of publication: